Interestingly, in infected humans, during the acute phase of the disease, only the shorter fragment was marginally higher in the plasma of patients with COVID-19 when compared with nondisease controls, whilst the larger fragment remained unaltered, suggesting that only a particular ACE2 fragment could serve as read-out of the processing subsequent to virus entry [17]. This evidence concerns the gene ACE2 and COVID-19.